Rxsight Stock Odds of Future Stock Price Finishing Over 44.79

RXST Stock  USD 44.83  0.22  0.49%   
Rxsight's future price is the expected price of Rxsight instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Rxsight performance during a given time horizon utilizing its historical volatility. Check out Rxsight Backtesting, Rxsight Valuation, Rxsight Correlation, Rxsight Hype Analysis, Rxsight Volatility, Rxsight History as well as Rxsight Performance.
For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.
  
At this time, Rxsight's Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.72 in 2024, despite the fact that Price To Operating Cash Flows Ratio is likely to grow to (31.73). Please specify Rxsight's target price for which you would like Rxsight odds to be computed.

Rxsight Target Price Odds to finish over 44.79

The tendency of Rxsight Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 44.79  in 90 days
 44.83 90 days 44.79 
roughly 96.0
Based on a normal probability distribution, the odds of Rxsight to stay above $ 44.79  in 90 days from now is roughly 96.0 (This Rxsight probability density function shows the probability of Rxsight Stock to fall within a particular range of prices over 90 days) . Probability of Rxsight price to stay between $ 44.79  and its current price of $44.83 at the end of the 90-day period is near 1 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.23 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Rxsight will likely underperform. Additionally Rxsight has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Rxsight Price Density   
       Price  

Predictive Modules for Rxsight

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Rxsight. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Rxsight's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
41.1843.5045.82
Details
Intrinsic
Valuation
LowRealHigh
33.4135.7349.31
Details
Naive
Forecast
LowNextHigh
41.5943.9146.22
Details
9 Analysts
Consensus
LowTargetHigh
30.7633.8037.52
Details

Rxsight Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Rxsight is not an exception. The market had few large corrections towards the Rxsight's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Rxsight, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Rxsight within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.37
β
Beta against Dow Jones1.23
σ
Overall volatility
3.39
Ir
Information ratio -0.15

Rxsight Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Rxsight for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Rxsight can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Rxsight generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 89.08 M. Net Loss for the year was (48.61 M) with profit before overhead, payroll, taxes, and interest of 21.33 M.
Rxsight currently holds about 128.62 M in cash with (41.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.65.
Rxsight has a strong financial position based on the latest SEC filings
Over 90.0% of the company shares are owned by institutional investors
Latest headline from zacks.com: RxSight Upgraded to Buy Heres What You Should Know

Rxsight Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Rxsight Stock often depends not only on the future outlook of the current and potential Rxsight's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rxsight's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding34.5 M
Cash And Short Term Investments127.2 M

Rxsight Technical Analysis

Rxsight's future price can be derived by breaking down and analyzing its technical indicators over time. Rxsight Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Rxsight. In general, you should focus on analyzing Rxsight Stock price patterns and their correlations with different microeconomic environments and drivers.

Rxsight Predictive Forecast Models

Rxsight's time-series forecasting models is one of many Rxsight's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Rxsight's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Rxsight

Checking the ongoing alerts about Rxsight for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Rxsight help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Rxsight generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 89.08 M. Net Loss for the year was (48.61 M) with profit before overhead, payroll, taxes, and interest of 21.33 M.
Rxsight currently holds about 128.62 M in cash with (41.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.65.
Rxsight has a strong financial position based on the latest SEC filings
Over 90.0% of the company shares are owned by institutional investors
Latest headline from zacks.com: RxSight Upgraded to Buy Heres What You Should Know

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.